Inflammaging in skin and other tissues - the roles of complement system and macrophage

Inflammation and Allergy - Drug Targets

Volumn 13, Issue 3, 2014, Pages 153-161

  Zhuang, Yong ^a   Lyga, John ^a  

^a Avon Products Inc   (United States)

Author keywords

Age related macular disease; Atherosclerosis; Complement; Inflammaging; Innate immune system; Macrophage; Skin

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; CHEMOKINE; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H; CYTOKINE; FREE RADICAL; GELATINASE B; INTERCELLULAR ADHESION MOLECULE 1; INTERSTITIAL COLLAGENASE; LIPOFUSCIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; PHOSPHOLIPID; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT MEMBRANE ATTACK COMPLEX; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MATRIX METALLOPROTEINASE; COMPLEMENT;

ADAPTIVE IMMUNITY; AMINO ACID SUBSTITUTION; ARTICLE; BRUCH MEMBRANE; CELL PHAGOCYTOSIS; COMPLEMENT SYSTEM; DNA POLYMORPHISM; EXTRACELLULAR MATRIX; GENE; GENOTYPE; HUMAN; INFLAMMATION; INNATE IMMUNITY; LENTIGO; MACROPHAGE; MICROGLIA; MONOCYTE; NEUTROPHIL; OPSONIZATION; PATHOGENESIS; PHENOTYPE; PHOTOAGING; PIGMENT EPITHELIUM; SKIN; SUBRETINAL NEOVASCULARIZATION; ULTRAVIOLET RADIATION; AGE RELATED MACULAR DEGENERATION; ATHEROSCLEROSIS; COMPLEMENT LECTIN PATHWAY; CUTANEOUS PARAMETERS; DERMATITIS; DERMOEPIDERMAL JUNCTION; DIABETES MELLITUS; AGING; ANIMAL; IMMUNOLOGY; MACULAR DEGENERATION; PATHOLOGY; PATHOPHYSIOLOGY;

AGING; ANIMALS; ATHEROSCLEROSIS; COMPLEMENT SYSTEM PROTEINS; CYTOKINES; HUMANS; IMMUNITY, INNATE; INFLAMMATION; MACROPHAGES; MACULAR DEGENERATION; SKIN AGING;

EID: 84904097530     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/1871528113666140522112003     Document Type: Article

References (102)

1. Gorman, C.; Park, A.; Dell, K. The fires within. Time: 2004.
2. Okin, D.; Medzhitov, R. Evolution of inflammatory diseases. Curr. Biol., 2012, 22 (17), R733-740.
3. El-Gabalawy, H.; Guenther, L. C.; Bernstein, C. N., Epidemiology of immune-mediated inflammatory diseases: incidence, prevalence, natural history, and comorbidities. J. Rheumatol. Suppl., 2010, 85, 2-10.
4. Franceschi, C.; Bonafe, M.; Valensin, S.; Olivieri, F.; De Luca, M.; Ottaviani, E.; De Benedictis, G. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N. Y. Acad. Sci., 2000, 908, 244-254.
5. Libby, P.; Okamoto, Y.; Rocha, V. Z.; Folco, E. Inflammation in atherosclerosis: transition from theory to practice. Circ. J., 2010, 74 (2), 213-220.
6. Goto, M. Inflammaging (inflammation + aging): A driving force for human aging based on an evolutionarily antagonistic pleiotropy theory? Biosci. Trends, 2008, 2 (6), 218-230.
7. Morales, I.; Farias, G.; Maccioni, R. B. Neuroimmunomodulation in the pathogenesis of Alzheimer's disease. Neuroimmunomodulation, 2010, 17 (3), 202-204.
8. Moore, K. J.; Tabas, I. Macrophages in the pathogenesis of atherosclerosis. Cell, 2011, 145 (3), 341-355.
9. Nakao, S.; Kuwano, T.; Tsutsumi-Miyahara, C.; Ueda, S.; Kimura, Y. N.; Hamano, S.; Sonoda, K. H.; Saijo, Y.; Nukiwa, T.; Strieter, R. M.; Ishibashi, T.; Kuwano, M.; Ono, M. Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1 beta-induced neovascularization and tumor growth. J. Clin. Invest., 2005, 115 (11), 2979-2991.
10. Apte, R. S.; Richter, J.; Herndon, J.; Ferguson, T. A. Macrophages inhibit neovascularization in a murine model of age-related macular degeneration. PLoS Med., 2006, 3 (8), e310.
11. Anderson, D. H.; Radeke, M. J.; Gallo, N. B.; Chapin, E. A.; Johnson, P. T.; Curletti, C. R.; Hancox, L. S.; Hu, J.; Ebright, J. N.; Malek, G.; Hauser, M. A.; Rickman, C. B.; Bok, D.; Hageman, G. S.; Johnson, L. V. The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog. Retin. Eye. Res., 2010, 29 (2), 95-112.
12. Torzewski, M.; Bhakdi, S. Complement and atherosclerosis-united to the point of no return? Clin. Biochem., 2013, 46 (1-2), 20-25.
13. Bennett, M. F.; Robinson, M. K.; Baron, E. D.; Cooper, K. D. Skin immune systems and inflammation: protector of the skin or promoter of aging? J. Invest. Dermatol. Symp. Proc., 2008, 13 (1), 15-19.
14. Kotnik, V. Complement in skin diseases. Acta. Dermatovenerol. Alp. Panonica. Adriat., 2011, 20 (1), 3-11.
15. Qu, H.; Ricklin, D.; Bai, H.; Chen, H.; Reis, E. S.; Maciejewski, M.; Tzekou, A.; DeAngelis, R. A.; Resuello, R. R.; Lupu, F.; Barlow, P. N.; Lambris, J. D. New analogs of the clinical complement inhibitor compstatin with subnanomolar affinity and enhanced pharmacokinetic properties. Immunobiology, 2013, 218 (4), 496-505.
16. Markiewski, M. M.; Lambris, J. D. The role of complement in inflammatory diseases from behind the scenes into the spotlight. Am. J. Pathol., 2007, 171 (3), 715-727.
17. Friedman, D. S.; O'Colmain, B. J.; Munoz, B.; Tomany, S. C.; McCarty, C.; de Jong, P. T.; Nemesure, B.; Mitchell, P.; Kempen, J.; Eye Diseases Prevalence Research, G. Prevalence of age-related macular degeneration in the United States. Arch. Ophthalmol., 2004, 122 (4), 564-572.
18. Lim, L. S.; Mitchell, P.; Seddon, J. M.; Holz, F. G.; Wong, T. Y. Age-related macular degeneration. Lancet, 2012, 379 (9827), 1728-1738.
19. Xu, H.; Chen, M.; Forrester, J. V. Para-inflammation in the aging retina. Prog. Retin. Eye. Res., 2009, 28 (5), 348-368.
20. Lin, T.; Walker, G. B.; Kurji, K.; Fang, E.; Law, G.; Prasad, S. S.; Kojic, L.; Cao, S.; White, V.; Cui, J. Z.; Matsubara, J. A. Parainflammation associated with advanced glycation endproduct stimulation of RPE in vitro: implications for age-related degenerative diseases of the eye. Cytokine, 2013, 62 (3), 369-381.
21. Mullins, R. F.; Russell, S. R.; Anderson, D. H.; Hageman, G. S. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J., 2000, 14 (7), 835-846.
22. Anderson, D. H.; Mullins, R. F.; Hageman, G. S.; Johnson, L. V., A role for local inflammation in the formation of drusen in the aging eye. Am. J. Ophthalmol., 2002, 134 (3), 411-431.
23. Crabb, J. W.; Miyagi, M.; Gu, X.; Shadrach, K.; West, K. A.; Sakaguchi, H.; Kamei, M.; Hasan, A.; Yan, L.; Rayborn, M. E.; Salomon, R. G.; Hollyfield, J. G. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A., 2002, 99 (23), 14682-14687.
24. Gulcan, H. G.; Alvarez, R. A.; Maude, M. B.; Anderson, R. E., Lipids of human retina, retinal pigment epithelium, and Bruch's membrane/choroid: comparison of macular and peripheral regions. Invest. Ophthalmol. Vis. Sci., 1993, 34 (11), 3187-3193.
25. Curcio, C. A.; Millican, C. L.; Bailey, T.; Kruth, H. S. Accumulation of cholesterol with age in human Bruch's membrane. Invest. Ophthalmol. Vis. Sci., 2001, 42 (1), 265-274.
26. Curcio, C. A.; Johnson, M.; Rudolf, M.; Huang, J. D. The oil spill in ageing Bruch membrane. Br. J. Ophthalmol., 2011, 95 (12), 1638-1645.
27. Johnson, L. V.; Leitner, W. P.; Staples, M. K.; Anderson, D. H. Complement activation and inflammatory processes in Drusen formation and age related macular degeneration. Exp. Eye. Res., 2001, 73 (6), 887-896.
28. Johnson, P. T.; Betts, K. E.; Radeke, M. J.; Hageman, G. S.; Anderson, D. H.; Johnson, L. V. Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid. Proc. Natl. Acad. Sci. U. S. A., 2006, 103 (46), 17456-17461.
29. Klein, R. J.; Zeiss, C.; Chew, E. Y.; Tsai, J. Y.; Sackler, R. S.; Haynes, C.; Henning, A. K.; SanGiovanni, J. P.; Mane, S. M.; Mayne, S. T.; Bracken, M. B.; Ferris, F. L.; Ott, J.; Barnstable, C.; Hoh, J. Complement factor H polymorphism in age-related macular degeneration. Science, 2005, 308 (5720), 385-389.
30. Spencer, K. L.; Hauser, M. A.; Olson, L. M.; Schmidt, S.; Scott, W. K.; Gallins, P.; Agarwal, A.; Postel, E. A.; Pericak-Vance, M. A.; Haines, J. L. Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration. Hum. Mol. Genet., 2007, 16 (16), 1986-1992.
31. Despriet, D. D.; van Duijn, C. M.; Oostra, B. A.; Uitterlinden, A. G.; Hofman, A.; Wright, A. F.; ten Brink, J. B.; Bakker, A.; de Jong, P. T.; Vingerling, J. R.; Bergen, A. A.; Klaver, C. C. Complement component C3 and risk of age-related macular degeneration. Ophthalmology, 2009, 116 (3), 474-480 e472.
32. Gold, B.; Merriam, J. E.; Zernant, J.; Hancox, L. S.; Taiber, A. J.; Gehrs, K.; Cramer, K.; Neel, J.; Bergeron, J.; Barile, G. R.; Smith, R. T.; Group, A. M. D. G. C. S.; Hageman, G. S.; Dean, M.; Allikmets, R. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat. Genet., 2006, 38 (4), 458-462.
33. Whitcup, S. M.; Sodhi, A.; Atkinson, J. P.; Holers, V. M.; Sinha, D.; Rohrer, B.; Dick, A. D. The role of the immune response in age-related macular degeneration. Int. J. Inflam., 2013, 2013, 348092.
34. Haines, J. L.; Hauser, M. A.; Schmidt, S.; Scott, W. K.; Olson, L. M.; Gallins, P.; Spencer, K. L.; Kwan, S. Y.; Noureddine, M.; Gilbert, J. R.; Schnetz-Boutaud, N.; Agarwal, A.; Postel, E. A.; Pericak-Vance, M. A. Complement factor H variant increases the risk of age-related macular degeneration. Science, 2005, 308 (5720), 419-421.
35. Edwards, A. O.; Ritter, R., 3rd; Abel, K. J.; Manning, A.; Panhuysen, C.; Farrer, L. A. Complement factor H polymorphism and age-related macular degeneration. Science, 2005, 308 (5720), 421-424.
36. Mandal, M. N.; Ayyagari, R. Complement factor H: spatial and temporal expression and localization in the eye. Invest. Ophthalmol. Vis. Sci., 2006, 47 (9), 4091-4097.
37. Chen, M.; Muckersie, E.; Robertson, M.; Forrester, J. V.; Xu, H. Up-regulation of complement factor B in retinal pigment epithelial cells is accompanied by complement activation in the aged retina. Exp. Eye. Res., 2008, 87 (6), 543-550.
38. Scholl, H. P.; Charbel Issa, P.; Walier, M.; Janzer, S.; Pollok-Kopp, B.; Borncke, F.; Fritsche, L. G.; Chong, N. V.; Fimmers, R.; Wienker, T.; Holz, F. G.; Weber, B. H.; Oppermann, M. Systemic complement activation in age-related macular degeneration. PLoS One, 2008, 3 (7), e2593.
39. Chen, M.; Forrester, J. V.; Xu, H. Synthesis of complement factor H by retinal pigment epithelial cells is down-regulated by oxidized photoreceptor outer segments. Exp. Eye. Res., 2007, 84 (4), 635-645.
40. Kim, Y. H.; He, S.; Kase, S.; Kitamura, M.; Ryan, S. J.; Hinton, D. R. Regulated secretion of complement factor H by RPE and its role in RPE migration. Graefes. Arch. Clin. Exp. Ophthalmol., 2009, 247 (5), 651-659.
41. Sparrow, J. R. Bisretinoids of RPE lipofuscin: trigger for complement activation in age-related macular degeneration. Adv. Exp. Med. Biol., 2010, 703, 63-74.
42. Zhou, J.; Jang, Y. P.; Kim, S. R.; Sparrow, J. R. Complement activation by photooxidation products of A2E, a lipofuscin constituent of the retinal pigment epithelium. Proc. Natl. Acad. Sci. U. S. A., 2006, 103 (44), 16182-16187.
43. Coleman, H. R.; Chan, C. C.; Ferris, F. L., 3rd; Chew, E. Y. Agerelated macular degeneration. Lancet, 2008, 372 (9652), 1835-1845.
44. Dastgheib, K.; Green, W. R. Granulomatous reaction to Bruch's membrane in age-related macular degeneration. Arch. Ophthalmol., 1994, 112 (6), 813-818.
45. Herrero, C.; Sebastian, C.; Marques, L.; Comalada, M.; Xaus, J.; Valledor, A. F.; Lloberas, J.; Celada, A. Immunosenescence of macrophages: reduced MHC class II gene expression. Exp. Gerontol., 2002, 37 (2-3), 389-394.
46. Gorgani, N. N.; He, J. Q.; Katschke, K. J., Jr.; Helmy, K. Y.; Xi, H.; Steffek, M.; Hass, P. E.; van Lookeren Campagne, M. Complement receptor of the Ig superfamily enhances complementmediated phagocytosis in a subpopulation of tissue resident macrophages. J. Immunol., 2008, 181 (11), 7902-7908.
47. Cao, X.; Shen, D.; Patel, M. M.; Tuo, J.; Johnson, T. M.; Olsen, T. W.; Chan, C. C. Macrophage polarization in the maculae of agerelated macular degeneration: a pilot study. Pathol. Int., 2011, 61 (9), 528-535.
48. Ma, W.; Coon, S.; Zhao, L.; Fariss, R. N.; Wong, W. T. A2E accumulation influences retinal microglial activation and complement regulation. Neurobiol. Aging, 2013, 34 (3), 943-960.
49. Ross, R. Atherosclerosis--an inflammatory disease. N. Engl. J. Med., 1999, 340 (2), 115-126.
50. Meuwissen, M.; van der Wal, A. C.; Niessen, H. W.; Koch, K. T.; de Winter, R. J.; van der Loos, C. M.; Rittersma, S. Z.; Chamuleau, S. A.; Tijssen, J. G.; Becker, A. E.; Piek, J. J. Colocalisation of intraplaque C reactive protein, complement, oxidised low density lipoprotein, and macrophages in stable and unstable angina and acute myocardial infarction. J. Clin. Pathol., 2006, 59 (2), 196-201.
51. Torzewski, M.; Klouche, M.; Hock, J.; Messner, M.; Dorweiler, B.; Torzewski, J.; Gabbert, H. E.; Bhakdi, S. Immunohistochemical demonstration of enzymatically modified human LDL and its colocalization with the terminal complement complex in the early atherosclerotic lesion. Arterioscler. Thromb. Vasc. Biol., 1998, 18 (3), 369-378.
52. Yasojima, K.; Schwab, C.; McGeer, E. G.; McGeer, P. L. Generation of C-reactive protein and complement components in atherosclerotic plaques. Am. J. Pathol., 2001, 158 (3), 1039-1051.
53. Hoke, M.; Speidl, W.; Schillinger, M.; Minar, E.; Zehetmayer, S.; Schonherr, M.; Wagner, O.; Mannhalter, C. Polymorphism of the complement 5 gene and cardiovascular outcome in patients with atherosclerosis. Eur. J. Clin. Invest., 2012, 42 (9), 921-926.
54. Boiocchi, C.; Zorzetto, M.; Sbarsi, I.; Pirotta, A.; Schirinzi, S.; Falcone, C.; Cuccia, M. CR1 genotype and haplotype involvement in coronary artery disease: the pivotal role of hypertension and dyslipidemia. Int. J. Mol. Med., 2009, 24 (2), 181-187.
55. Volcik, K. A.; Ballantyne, C. M.; Braun, M. C.; Coresh, J.; Mosley, T. H.; Boerwinkle, E. Association of the complement factor H Y402H polymorphism with cardiovascular disease is dependent upon hypertension status: The ARIC study. Am. J. Hypertens., 2008, 21 (5), 533-538.
56. Tedesco, F.; Fischetti, F.; Pausa, M.; Dobrina, A.; Sim, R. B.; Daha, M. R. Complement-endothelial cell interactions: pathophysiological implications. Mol. Immunol., 1999, 36 (4-5), 261-268.
57. Seifert, P. S.; Hugo, F.; Tranum-Jensen, J.; Zahringer, U.; Muhly, M.; Bhakdi, S. Isolation and characterization of a complementactivating lipid extracted from human atherosclerotic lesions. J. Exp. Med., 1990, 172 (2), 547-557.
58. Bhakdi, S.; Dorweiler, B.; Kirchmann, R.; Torzewski, J.; Weise, E.; Tranum-Jensen, J.; Walev, I.; Wieland, E. On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety. J. Exp. Med., 1995, 182 (6), 1959-1971.
59. Bhakdi, S.; Lackner, K. J.; Han, S. R.; Torzewski, M.; Husmann, M. Beyond cholesterol: the enigma of atherosclerosis revisited. Thromb. Haemost., 2004, 91 (4), 639-645.
60. Leibundgut, G.; Witztum, J. L.; Tsimikas, S. Oxidation-specific epitopes and immunological responses: Translational biotheranostic implications for atherosclerosis. Curr. Opin. Pharmacol., 2013, 13 (2), 168-179.
61. Bochkov, V. N.; Oskolkova, O. V.; Birukov, K. G.; Levonen, A. L.; Binder, C. J.; Stockl, J. Generation and biological activities of oxidized phospholipids. Antioxid. Redox. Signal., 2010, 12 (8), 1009-1059.
62. Fisher, G. J.; Kang, S.; Varani, J.; Bata-Csorgo, Z.; Wan, Y.; Datta, S.; Voorhees, J. J. Mechanisms of photoaging and chronological skin aging. Arch. Dermatol., 2002, 138 (11), 1462-1470.
63. Makrantonaki, E.; Zouboulis, C. C. Molecular mechanisms of skin aging: state of the art. Ann. N. Y. Acad. Sci., 2007, 1119, 40-50.
64. Kim, H. H.; Cho, S.; Lee, S.; Kim, K. H.; Cho, K. H.; Eun, H. C.; Chung, J. H. Photoprotective and anti-skin-aging effects of eicosapentaenoic acid in human skin in vivo. J. Lipid Res., 2006, 47 (5), 921-930.
65. Polte, T.; Tyrrell, R. M. Involvement of lipid peroxidation and organic peroxides in UVA-induced matrix metalloproteinase-1 expression. Free Radic. Biol. Med., 2004, 36 (12), 1566-1574.
66. Robinson, M. K.; Binder, R. L.; Griffiths, C. E. Genomic-driven insights into changes in aging skin. J. Drugs Dermatol., 2009, 8 (7 Suppl), s8-11.
67. Urschitz, J.; Iobst, S.; Urban, Z.; Granda, C.; Souza, K. A.; Lupp, C.; Schilling, K.; Scott, I.; Csiszar, K.; Boyd, C. D. A serial analysis of gene expression in sun-damaged human skin. J. Invest. Dermatol., 2002, 119 (1), 3-13.
68. Yan, W.; Zhang, L. L.; Yan, L.; Zhang, F.; Yin, N. B.; Lin, H. B.; Huang, C. Y.; Wang, L.; Yu, J.; Wang, D. M.; Zhao, Z. M. Transcriptome analysis of skin photoaging in chinese females reveals the involvement of skin homeostasis and metabolic changes. PLoS One, 2013, 8 (4), e61946.
69. Wood, L. C.; Elias, P. M.; Calhoun, C.; Tsai, J. C.; Grunfeld, C.; Feingold, K. R. Barrier disruption stimulates interleukin-1 alpha expression and release from a pre-formed pool in murine epidermis. J. Invest. Dermatol., 1996, 106 (3), 397-403.
70. Kawaguchi, Y.; Tanaka, H.; Okada, T.; Konishi, H.; Takahashi, M.; Ito, M.; Asai, J. The effects of ultraviolet A and reactive oxygen species on the mRNA expression of 72-kDa type IV collagenase and its tissue inhibitor in cultured human dermal fibroblasts. Arch. Dermatol. Res., 1996, 288 (1), 39-44.
71. Gonzalez, S.; Pathak, M. A. Inhibition of ultraviolet-induced formation of reactive oxygen species, lipid peroxidation, erythema and skin photosensitization by polypodium leucotomos. Photodermatol. Photoimmunol. Photomed., 1996, 12 (2), 45-56.
72. Bielenberg, D. R.; Bucana, C. D.; Sanchez, R.; Donawho, C. K.; Kripke, M. L.; Fidler, I. J. Molecular regulation of UVB-induced cutaneous angiogenesis. J. Invest. Dermatol., 1998, 111 (5), 864-872.
73. Hruza, L. L.; Pentland, A. P. Mechanisms of UV-induced inflammation. J. Invest. Dermatol., 1993, 100 (1), 35S-41S.
74. Rijken, F.; Kiekens, R. C.; Bruijnzeel, P. L. Skin-infiltrating neutrophils following exposure to solar-simulated radiation could play an important role in photoageing of human skin. Br. J. Dermatol., 2005, 152 (2), 321-328.
75. Kang, K.; Gilliam, A. C.; Chen, G.; Tootell, E.; Cooper, K. D. In human skin, UVB initiates early induction of IL-10 over IL-12 preferentially in the expanding dermal monocytic/macrophagic population. J. Invest. Dermatol., 1998, 111 (1), 31-38.
76. Meunier, L.; Bata-Csorgo, Z.; Cooper, K. D. In human dermis, ultraviolet radiation induces expansion of a CD36+ CD11b+ CD1-macrophage subset by infiltration and proliferation; CD1+ Langerhans-like dendritic antigen-presenting cells are concomitantly depleted. J. Invest. Dermatol., 1995, 105 (6), 782-788.
77. Goetzl, E. J.; Banda, M. J.; Leppert, D. Matrix metalloproteinases in immunity. J. Immunol., 1996, 156 (1), 1-4.
78. Katiyar, S. K.; Mukhtar, H. Green tea polyphenol (-)-epigallocatechin-3-gallate treatment to mouse skin prevents UVBinduced infiltration of leukocytes, depletion of antigen-presenting cells, and oxidative stress. J. Leukoc. Biol., 2001, 69 (5), 719-726.
79. Bosset, S.; Bonnet-Duquennoy, M.; Barre, P.; Chalon, A.; Kurfurst, R.; Bonte, F.; Schnebert, S.; Le Varlet, B.; Nicolas, J. F. Photoageing shows histological features of chronic skin inflammation without clinical and molecular abnormalities. Br. J. Dermatol., 2003, 149 (4), 826-835.
80. Uitto, J. The role of elastin and collagen in cutaneous aging: intrinsic aging versus photoexposure. J. Drugs Dermatol., 2008, 7 (2 Suppl), s12-16.
81. Pillai, S.; Oresajo, C.; Hayward, J. Ultraviolet radiation and skin aging: roles of reactive oxygen species, inflammation and protease activation, and strategies for prevention of inflammation-induced matrix degradation-a review. Int. J. Cosmet. Sci., 2005, 27 (1), 17-34.
82. Brenneisen, P.; Sies, H.; Scharffetter-Kochanek, K. Ultraviolet-B irradiation and matrix metalloproteinases: from induction via signaling to initial events. Ann. N. Y. Acad. Sci., 2002, 973, 31-43.
83. Kupper, T. S.; Groves, R. W. The interleukin-1 axis and cutaneous inflammation. J. Invest. Dermatol., 1995, 105 (1 Suppl), 62S-66S.
84. Shreedhar, V.; Giese, T.; Sung, V. W.; Ullrich, S. E. A cytokine cascade including prostaglandin E2, IL-4, and IL-10 is responsible for UV-induced systemic immune suppression. J. Immunol., 1998, 160 (8), 3783-3789.
85. Takashima, A.; Bergstresser, P. R. Impact of UVB radiation on the epidermal cytokine network. Photochem. Photobiol., 1996, 63 (4), 397-400.
86. Hirao, T.; Aoki, H.; Yoshida, T.; Sato, Y.; Kamoda, H. Elevation of interleukin 1 receptor antagonist in the stratum corneum of sunexposed and ultraviolet B-irradiated human skin. J. Invest. Dermatol., 1996, 106 (5), 1102-1107.
87. Fagot, D.; Asselineau, D.; Bernerd, F. Matrix metalloproteinase-1 production observed after solar-simulated radiation exposure is assumed by dermal fibroblasts but involves a paracrine activation through epidermal keratinocytes. Photochem. Photobiol., 2004, 79 (6), 499-505.
88. Rijken, F.; Bruijnzeel, P. L. The pathogenesis of photoaging: the role of neutrophils and neutrophil-derived enzymes. J. Investig. Dermatol. Symp. Proc., 2009, 14 (1), 67-72.
89. Takahara, M.; Kang, K.; Liu, L.; Yoshida, Y.; McCormick, T. S.; Cooper, K. D. iC3b arrests monocytic cell differentiation into CD1c-expressing dendritic cell precursors: a mechanism for transiently decreased dendritic cells in vivo after human skin injury by ultraviolet B. J. Invest. Dermatol., 2003, 120 (5), 802-809.
90. Yoshida, Y.; Kang, K.; Berger, M.; Chen, G.; Gilliam, A. C.; Moser, A.; Wu, L.; Hammerberg, C.; Cooper, K. D. Monocyte induction of IL-10 and down-regulation of IL-12 by iC3b deposited in ultraviolet-exposed human skin. J. Immunol., 1998, 161 (11), 5873-5879.
91. Hammerberg, C.; Duraiswamy, N.; Cooper, K. D. Active induction of unresponsiveness (tolerance) to DNFB by in vivo ultravioletexposed epidermal cells is dependent upon infiltrating class II MHC+ CD11bbright monocytic/macrophagic cells. J. Immunol., 1994, 153 (11), 4915-4924.
92. Handoko, H. Y.; Rodero, M. P.; Boyle, G. M.; Ferguson, B.; Engwerda, C.; Hill, G.; Muller, H. K.; Khosrotehrani, K.; Walker, G. J. UVB-induced melanocyte proliferation in neonatal mice driven by CCR2-independent recruitment of Ly6c(low)MHCII(hi) macrophages. J. Invest. Dermatol., 2013, 133 (7), 1803-1812.
93. Fukuoka, Y.; Hite, M. R.; Dellinger, A. L.; Schwartz, L. B. Human skin mast cells express complement factors C3 and C5. J. Immunol., 2013, 191 (4), 1827-1834.
94. Colten, H. R.; Strunk, R. C.; Perlmutter, D. H.; Cole, F. S. Regulation of complement protein biosynthesis in mononuclear phagocytes. Ciba. Found. Symp., 1986, 118, 141-154.
95. Pasch, M. C.; Van Den Bosch, N. H.; Daha, M. R.; Bos, J. D.; Asghar, S. S. Synthesis of complement components C3 and factor B in human keratinocytes is differentially regulated by cytokines. J. Invest. Dermatol., 2000, 114 (1), 78-82.
96. Katz, Y.; Nadiv, O.; Rapoport, M. J.; Loos, M. IL-17 regulates gene expression and protein synthesis of the complement system, C3 and factor B, in skin fibroblasts. Clin. Exp. Immunol., 2000, 120 (1), 22-29.
97. Rauterberg, A.; Jung, E. G.; Rauterberg, E. W. Complement deposits in epidermal cells after ultraviolet B exposure. Photodermatol. Photoimmunol. Photomed., 1993, 9 (4), 135-143.
98. Bastiaens, M.; Hoefnagel, J.; Westendorp, R.; Vermeer, B. J.; Bouwes Bavinck, J. N. Solar lentigines are strongly related to sun exposure in contrast to ephelides. Pigment Cell Res., 2004, 17 (3), 225-229.
99. Hodgson, C. Senile lentigo. Arch. Dermatol., 1963, 87, 197-207.
100. Noblesse, E.; Nizard, C.; Cario-Andre, M.; Lepreux, S.; Pain, C.; Schnebert, S.; Taieb, A.; Kurfurst, R. Skin ultrastructure in senile lentigo. Skin Pharmacol. Physiol., 2006, 19 (2), 95-100.
101. Aoki, H.; Moro, O.; Tagami, H.; Kishimoto, J. Gene expression profiling analysis of solar lentigo in relation to immunohistochemical characteristics. Br. J. Dermatol., 2007, 156 (6), 1214-1223.
102. Doles, J.; Storer, M.; Cozzuto, L.; Roma, G.; Keyes, W. M. Ageassociated inflammation inhibits epidermal stem cell function. Genes Dev., 2012, 26 (19), 2144-2153.